# Effect of Buprenorphine/Naloxone Continuation on Pain Control and Opioid Use

> **NCT03266445** · PHASE4 · UNKNOWN · sponsor: **Massachusetts General Hospital** · enrollment: 76 (estimated)

## Conditions studied

- Opioid-use Disorder
- Pain, Acute
- Surgery

## Interventions

- **DRUG:** buprenorphine/naloxone

## Key facts

- **NCT ID:** NCT03266445
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-05
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-02-26
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2018-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03266445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03266445, "Effect of Buprenorphine/Naloxone Continuation on Pain Control and Opioid Use". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03266445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*